期刊文献+

神经内分泌拮抗剂治疗心力衰竭的研究进展

Progress of neureurohormonal antagonists in the treatment of chronic heart failure
下载PDF
导出
摘要 慢性心力衰竭(CHF)发病率和死亡率均很高,内分泌激活是其重要特点,神经内分泌拮抗剂对CHF治疗作用,本文对其临床研究做一综述。 Chronic heart failure (CHF)is described as a clinical syn- drome with high morbidity and mortality. In general, the pathophysiolo-gic mechanisms is responsible for cardiac remodeling and characterized by neuroendocrine activation. It shown that the neurohormonal antagonists had clinical efficacy in the treatment of CHF. We review some neurohormonal antagonists for CHF therapy, to provide reference for clinical parmacological therapies.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2006年第4期307-309,共3页 The Chinese Journal of Clinical Pharmacology
关键词 慢性心力衰竭 神经内分泌拮抗剂 chronic heart failure pharmacological therapies neurohormonal antagonists
  • 相关文献

参考文献11

  • 1Rodriguez Artalejo F,Banegas JR,et al.Epidemiology of heart failure[J].Esp Cardiolo,2004 ;57:163-170.
  • 2Fedak PW,Verma S,Weisel RD,et al.Cardia remodelling and failure from molecules to man (part Ⅱ)[J].Cardiovasc Pathol,2005; 14:109-119.
  • 3卢永昕.慢性心力衰竭的临床评估和治疗原则——2005ACC/AHA慢性心力衰竭治疗指南简介[J].临床心血管病杂志,2005,21(11):691-695. 被引量:24
  • 4刘亚欣,周宪梁.β-肾上腺素能受体阻滞剂治疗慢性心力衰竭的研究进展[J].中国分子心脏病学杂志,2004,4(4):243-248. 被引量:13
  • 5CIBIS-Ⅱ Investigators and Committee.The Cardiac insufficiency bisoprolo study Ii (CIBIS-Ⅱ):a randomised trail[J].lancet,1999; 353:9-13.
  • 6MERIT-HF Study Group.Effect of metoprolol CR/XLin chronic heart failure:Metopolol CR/XL Randomzed investigation trail in cingestive heart failure (MERIT-HF)[J].Lancet,1999 ;353:9-13.
  • 7Packer M,Coats AJS,Fowler MB,et al.Effeect of carvedilol on survival in severe chronic heart failure[J].N Engl J Med,2001;344:1651-1658.
  • 8Poole Wilson PA,Swedberg K,Gleland JG,et al.Carvedilol or metoprolol European trail investigators.:randomised controlled trail[J].Lancet,2003 ;362:7-13.
  • 9The Beta-Blocker Evaluation of Survival Trail Investigators.A trail of the beta-blocker bucindolol in patients with advanced chronic heart failur[J].N Engl J Med,2001 ;344:1659-1667.
  • 10Pitt B,Zannad F,Pemme WJ,et al.The Randomized Aldactone Evaluation Study Investigations.The effect of spironalacton on morbidity and mortality in patients with severe heart failure[J].N Engl J Med,1999 ;341:709-777.

二级参考文献34

  • 1[1]Packer M.The neurohumoral hypothesis:a theory to explain the mechanism of disease progression in heart failure.J Am Coll Cardiol,1992,20:248-254
  • 2[2]Metra M,Nodari S,Aloia A,et al.A rationale for the use of β-blocker as standard treatment for heart failure.Am Heart J,2000,139:511-521
  • 3[3]Coh JN,Levine TB,Ohvari MT,et al.Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.N Eng J Med,1984,311:819-823
  • 4[4]Doughty RN,Whalley GA,Gamble G,et al.On behalf of the Australia/New Zealand Heart Failure Research Collaborative Group.Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease.J Am Coll Cardiol,1997,29:1060-1066
  • 5[5]Lechat PP,Packer M,Chalon S,et al.Clinical effects of β-adrenergic blockade in chronic heart failure:a meta-analysis of double-blind,placebo-controlled,randomised trials.Circulation,1998,98:1184-1191
  • 6[6]MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).Lancet,1999,353:2001-2007
  • 7[7]CIBIS-II Investigators and Committees.The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II):a randomised trial.Lancet,1999,353:9-13
  • 8[8]Packer M.On behalf of the COPERNICUS investigators.Results of the COPERNICUS Study.Data presented at the 73rd Meeting of the American Heart Association.New Orleans,2000
  • 9[9]Parcker M,Coats AJS,Fowler MB,et al.The effect of carvedilol on morbidity and mortality in severe chronic heart failure.N Eng J Med,2001,344:1349-1355
  • 10[10]Poole-wilson PA,Swedberg K,Gleland JG,et al.Carvedilol Or Metoprolol European Trial Investigators.Comparison of carredilol and metoprolol on clinical out in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET):randomised controlled trial.Lancet,2003,362:7-13

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部